SCHEMBL17663

SCHEMBL17663

FC(F)(F)c1cc(Cl)ncn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.56
CHKA P35790 1/20 0.56
SMARCA2 P51531 2/20 0.41
SMARCA4 P51532 2/20 0.41
LOXL2 Q9Y4K0 2/20 0.35
LOX P28300 1/20 0.34
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TRPV4 Q9HBA0 1/20 0.32
NT5E P21589 1/20 0.32
MAP4K4 O95819 1/20 0.31
AAK1 Q2M2I8 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
PTGS2 P35354 2/20 0.31
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16513403 0.84 CA2 (0.39) CA2CHKASMARCA2SMARCA4MEN1
SCHEMBL1660333 0.84 CA2 (0.39) CA2CHKASMARCA2SMARCA4MEN1
SCHEMBL1661082 0.82 CA2 (0.38) CA2CHKAMEN1KMT2AAAK1
SCHEMBL24136814 0.82 CA2 (0.38) CA2CHKAMEN1KMT2A
SCHEMBL27264896 0.82 CA2 (0.68) CA2CHKASMARCA2SMARCA4LOXL2
SCHEMBL16532258 0.80 CA2 (0.36) CA2CHKAMEN1KMT2AAAK1
SCHEMBL29416323 0.76 NPC1 (0.33) CA2CHKAMEN1KMT2ANPC1
SCHEMBL1661897 0.76 NPC1 (0.33) CA2CHKAMEN1KMT2ANPC1
SCHEMBL16513728 0.74 NPC1 (0.33) CA2CHKAMEN1KMT2ANPC1
SCHEMBL1660874 0.73 NPC1 (0.35) MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115124475-B Pyrimidine derivative and preparation method and application thereof 贵阳学院 2023-11-10 CN claimed
CN-115124475-A Pyrimidine derivative and preparation method and application thereof 贵阳学院 2022-09-30 CN claimed
CN-102887860-B Preparation method of 4-chloro-6-trifluoromethylpyrimidine type compound SHANGHAI TITAN TECHNOLOGY CO LTD 2015-07-01 CN claimed
CN-102887860-A Preparation method of 4-chloro-6-trifluoromethylpyrimidine type compound SHANGHAI TITAN TECHNOLOGY CO LTD 2013-01-23 CN claimed
CN-117126147-B Pyrimidine substituted 1,3, 4-oxadiazole derivative, preparation method and application 贵阳学院 2026-05-15 CN disclosed
WO-2026101698-A1 HEPCIDIN MIMETIC COMPOUNDS AND USES THEREOF PROTAGONIST THERAPEUTICS, INC. (US) 2026-05-15 WO disclosed
EP-4735445-A1 KRAS MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2026-05-06 EP disclosed
EP-4735453-A1 KRAS MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2026-05-06 EP disclosed
US-20260083129-A1 PYRAZOLE AMIDE INSECTICIDES FMC CORP (US) 2026-03-26 US disclosed
EP-4695260-A1 KRAS MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2026-02-18 EP disclosed
US-12545682-B2 Heterocyclic derivatives as P2X7 receptor antagonists BREYE THERAPEUTICS APS (DK) 2026-02-10 US disclosed
EP-4680609-A1 KRAS MODULATORS AND USES THEREOF Quanta Therapeutics, Inc. (US) 2026-01-21 EP disclosed
WO-2003004474-A1 PESTICIDALLY ACTIVE AMINOACETONITRILES SYNGENTA PARTICIPATIONS AG (CH) 2003-01-16 WO disclosed
WO-2002038569-A1 IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2002-05-16 WO disclosed
EP-0758321-B1 3-SUBSTITUTED PYRIDINE COMPOUNDS AND DERIVATIVES THEREOF AS HERBICIDES ZENECA LTD (GB) 1999-04-21 EP disclosed
US-5763357-A HERBICIDES ZENECA LIMITED (GB) 1998-06-09 US disclosed
US-5714438-A PRE- AND POSTEMERGENCE HERBICIDES; BRAOADLEAF PLANTS AND GRASSES ZENECA LIMITED (GB) 1998-02-03 US disclosed
EP-0758321-A1 3-SUBSTITUTED PYRIDINE COMPOUNDS AND DERIVATIVES THEREOF AS HERBICIDES ZENECA LIMITED (GB) 1997-02-19 EP disclosed
US-5595958-A HERBICIDES ZENECA LIMITED (GB) 1997-01-21 US disclosed
WO-1995029893-A1 3-SUBSTITUTED PYRIDINE COMPOUNDS AND DERIVATIVES THEREOF AS HERBICIDES ZENECA LIMITED (GB) 1995-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260083129-A1 PYRAZOLE AMIDE INSECTICIDES CBR3, CBR1, NOX3 CA2 2044/4885CHKA 1594/4885SMARCA2 4754/4885
US-12545682-B2 Heterocyclic derivatives as P2X7 receptor antagonists P2RX7, P2RX3, P2RX1 CA2 633/4885CHKA 1489/4885SMARCA2 4760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.